Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Flachenecker

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Der Nervenarzt|March 31, 1999
[PRISMS Study. Interferon-beta 1a (Rebif) in relapsing multiple sclerosis]H P Hartung, P Flachenecker, F X Weilbach, et al.
Journal of Neurology|January 1, 1997
Distal muscular dystrophy of Miyoshi type. Report of two cases and review of the literatureP Flachenecker, R Kiefer, M Naumann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disabilityP Flachenecker, K Reiners, M Krauser, et al.
Der Nervenarzt|April 8, 2011
[MusiQol: international questionnaire investigating quality of life in multiple sclerosis: validation results for the German subpopulation in an international comparison]P Flachenecker, U Vogel, M C Simeoni, et al.
Journal of Neurology|August 27, 1999
Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intoleranceP Flachenecker, A Wolf, M Krauser, et al.
Neurology|July 1, 1996
Eyeball pressure testing in the evaluation of serious bradyarrhythmias in Guillain-Barré syndromeP Flachenecker, W Müllges, P Wermuth, et al.
Lancet (London, England)|January 25, 1997
Botulinum toxin for palmar hyperhidrosisM Naumann, P Flachenecker, E B Bröcker, et al.
Der Nervenarzt|September 15, 2005
["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"]P Flachenecker, G Müller, H König, et al.
Muscle & Nerve|December 8, 1998
Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxinI Bergmann, M Dauphin, M Naumann, et al.
Der Nervenarzt|October 25, 2017
[What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity]T Henze, W Feneberg, P Flachenecker, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Der Nervenarzt|March 31, 1999
[PRISMS Study. Interferon-beta 1a (Rebif) in relapsing multiple sclerosis]H P Hartung, P Flachenecker, F X Weilbach, et al.
Journal of Neurology|January 1, 1997
Distal muscular dystrophy of Miyoshi type. Report of two cases and review of the literatureP Flachenecker, R Kiefer, M Naumann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disabilityP Flachenecker, K Reiners, M Krauser, et al.
Der Nervenarzt|April 8, 2011
[MusiQol: international questionnaire investigating quality of life in multiple sclerosis: validation results for the German subpopulation in an international comparison]P Flachenecker, U Vogel, M C Simeoni, et al.
Journal of Neurology|August 27, 1999
Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intoleranceP Flachenecker, A Wolf, M Krauser, et al.
Neurology|July 1, 1996
Eyeball pressure testing in the evaluation of serious bradyarrhythmias in Guillain-Barré syndromeP Flachenecker, W Müllges, P Wermuth, et al.
Lancet (London, England)|January 25, 1997
Botulinum toxin for palmar hyperhidrosisM Naumann, P Flachenecker, E B Bröcker, et al.
Der Nervenarzt|September 15, 2005
["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"]P Flachenecker, G Müller, H König, et al.
Muscle & Nerve|December 8, 1998
Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxinI Bergmann, M Dauphin, M Naumann, et al.
Der Nervenarzt|October 25, 2017
[What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity]T Henze, W Feneberg, P Flachenecker, et al.
Pageof 5